Mosaic ImmunoEngineering, Inc.
Overview
Mosaic ImmunoEngineering, Inc. is a biotechnology company focused on the development of novel immunotherapies for the treatment of various cancers and infectious diseases. Utilizing its proprietary technology platform, the company aims to harness the immune system to target and eliminate cancer cells effectively.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Mosaic ImmunoEngineering, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
454 Life Sciences Corporation
United States
ABC Health Research Institute
USA
AC Biotech Incorporated
USA
Aequita Bioworks Inc.
United States
AGC Biopharma, Inc.
USA
American Cyanamid Company (as Wyeth-Ayerst Laboratories)
United States
AS Pharmaceutical Inc.
USA
Ascendia Pharmaceutical Solutions, Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.